Remaxol® in Mechanical Jaundice of Non-malignant Origin

Summary

The purpose of this study is to assess the safety and efficacy of Remaxol (succinate + methionine + inosine + nicotinamide; POLYSAN Ltd., Russia) infusions at dose 400 and 800 ml to treat mechanical jaundice of non-tumor cause during the first week after surgery.

Timeline

Start

2017-04-03

Primary completion

2020-03-31

Completion

2020-04-13

Drugs

Indications